Increased plasma levels of NT-proBNP, Troponin T and GDF-15 are driven by persistent AF and associated comorbidities: Data from the AF-RISK study

MLA

L.M.G. Meems, et al. “Increased Plasma Levels of NT-ProBNP, Troponin T and GDF-15 Are Driven by Persistent AF and Associated Comorbidities: Data from the AF-RISK Study.” International Journal of Cardiology: Heart & Vasculature, vol. 39, no. 100987-, Apr. 2022. EBSCOhost, https://doi.org/10.1016/j.ijcha.2022.100987.

APA

L.M.G. Meems, V. Artola Arita, M. Velt, E.A.M.P. Dudink, H.J.G.M. Crijns, I.C. Van Gelder, & M. Rienstra. (2022). Increased plasma levels of NT-proBNP, Troponin T and GDF-15 are driven by persistent AF and associated comorbidities: Data from the AF-RISK study. International Journal of Cardiology: Heart & Vasculature, 39(100987-). https://doi.org/10.1016/j.ijcha.2022.100987

Chicago

L.M.G. Meems, V. Artola Arita, M. Velt, E.A.M.P. Dudink, H.J.G.M. Crijns, I.C. Van Gelder, and M. Rienstra. 2022. “Increased Plasma Levels of NT-ProBNP, Troponin T and GDF-15 Are Driven by Persistent AF and Associated Comorbidities: Data from the AF-RISK Study.” International Journal of Cardiology: Heart & Vasculature 39 (100987-). doi:10.1016/j.ijcha.2022.100987.